Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 19,792 results that match your search.19,792 results
  • Ugur G Yalçiner and Irmak Yalçiner of Yalçiner Patent and Consulting look at the turning point in modern day Turkey’s industrial property system
  • Sponsored by Chang Tsi & Partners
    Michael Wu and Darren Leng of Chang Tsi & Partners provide a guide to the primary characteristics of China's administrative patent protection system and how to obtain an administrative injunction
  • Sponsored by Wanhuida Intellectual Property
    Paul Ranjard, Huang Hui, and Zhu Zhigang of Wanhuida Intellectual Property explain the proposed amendments to China’s Trademark Law, their ramifications, and the persisting issue surrounding the ‘right to use’
  • Sponsored by AnJie Law Firm
    On August 28 2020, the Chinese Supreme People's Court (SPC) granted the very first anti-suit injunction in the standard essential patent (SEP) royalty dispute case of Huawei v Conversant, which enjoined Conversant Wireless Licensing (Conversant) from seeking enforcement of the Dusseldorf regional court's injunction ruling against Huawei Technologies (Huawei). This case thus opened the door for Chinese courts to issue anti-suit injunctions (ASIs).
  • Erich Andersen recently explained the thinking behind Microsoft joining the Open Invention Network and the LOT Network
  • Koreans who like to wash down a piece of Camembert de Normandie with a glass of Bordeaux wine will find it easier to obtain the genuine products from next year when an EU-Korea FTA comes into effect
  • In Human Genome Sciences v Eli Lilly, the UK's Supreme Court debated whether the UK has correctly followed European patent law on industrial application. The case involves a split between the England & Wales Court of Appeal and the EPO Technical Board of Appeal (TBA). The UK courts have revoked HGS's patent for the Neutrokine-a protein – even though the appellant's amended set of claims had been accepted by the TBA. This is the first patent case to be heard by the UK Supreme Court. It has been asked to rule whether the Court of Appeal correctly applied the principles of law established by the EPO relating to Article 57 of the EPC and whether the amended claims are sufficient to maintain the patent under UK law. On day two of the three-day hearing, HGS's patent was said to contain a "lot of guff" according to Lord Justice Neuberger, but whether that should invalidate the patent was the key question. The decision is expected before the end of this year.
  • An attorney who drafted two innovation patents that his client last week successfully defended in the Australian High Court has urged IP owners to make more use of the system – before it is too late
  • As the Supreme Court is considering whether the Federal Circuit’s ruling in Nautilus v Biosig allows too much ambiguity in patents, the Federal Circuit found itself in the awkward position of ruling on whether the USPTO allows too little
  • The Municipal Court in Prague stated in Decision 9Ca 68/2003-36 that use of a trade mark includes not only direct use of a mark through placing on products or packaging, but also indirect use in connection with those products or services, for example on accompanying documents or advertising. In this decision the Municipal Court refused an action against the decision of the President of the Industrial Property Office concerning the cancellation of a trade mark due to non-use.